ArticleClinical neurology and neurosurgery2021

SARS-CoV-2/COVID-19 in multiple sclerosis patients receiving disease-modifying therapy.

Monika Adamczyk-Sowa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.